CE vs NTLA · rev $10.28B vs rev $57.9M
Celanese Corporation (CE) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
CE currently screens at market cap $5.92B. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the CE and NTLA stock pages for the full models.
Not investment advice.